Matrix metalloproteinase-9 genotype as a potential genetic marker for abdominal aortic aneurysm

Circulation: Cardiovascular Genetics

Volumn 5, Issue 5, 2012, Pages 529-537

  Duellman, Tyler ^a   Warren, Christopher L ^b   Peissig, Peggy ^c   Wynn, Martha ^a   Yang, Jay ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Illumavista Biosciences LLC   (United States)

^c Biomedical Informatics Research Center   (United States)

Author keywords

Aneurysm; Case control study; Genetic association; MMP; Single nucleotide polymorphism genetics

Indexed keywords

GELATINASE B;

ABDOMINAL AORTA ANEURYSM; ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MARKER; GENOTYPE; HUMAN; HUMAN CELL; HUMAN GENOME; MAJOR CLINICAL STUDY; MALE; MATRIX METALLOPROTEINASE 9 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING;

AORTIC ANEURYSM, ABDOMINAL; CASE-CONTROL STUDIES; DEMOGRAPHY; EXONS; GENETIC HETEROGENEITY; GENOTYPE; HUMANS; LOGISTIC MODELS; MATRIX METALLOPROTEINASE 9; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84868614241     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.112.963082     Document Type: Article

References (30)

1. Sandford RM, Bown MJ, London NJ, Sayers RD. The genetic basis of abdominal aortic aneurysms: a review. Eur J Vasc Endovasc Surg. 2007;33:381-390. (Pubitemid 46336592)
2. Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg. 2010;52:539-548.
3. Johansen K, Koepsell T. Familial tendency for abdominal aortic aneurysms. JAMA. 1986;256:1934-1936. (Pubitemid 16033398)
4. Thompson AR, Drenos F, Hafez H, Humphries SE. Candidate gene association studies in abdominal aortic aneurysm disease: a review and metaanalysis. Eur J Vasc Endovasc Surg. 2008;35:19-30. (Pubitemid 350235228)
5. McColgan P, Peck GE, Greenhalgh RM, Sharma P. The genetics of abdominal aortic aneurysms: a comprehensive meta-analysis involving eight candidate genes in over 16, 700 patients. Int Surg. 2009;94:350-358.
6. Zhang B, Ye S, Herrmann SM, Eriksson P, De Maat M, Evans A, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999;99:1788-1794. (Pubitemid 29181405)
7. Janssens S, Lijnen HR. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models? Cardiovasc Res. 2006;69:585-594. (Pubitemid 43139722)
8. Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA. Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg. 2004;78:2106-10; discussion 2110. (Pubitemid 39556304)
9. McMillan WD, Pearce WH. Increased plasma levels of metallopro-teinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg. 1999;29:122-7; discussion 127.
10. McCarty C A W R, Giampietrao PF, Wesbrook SD, Caldwell MD. Marsh-fibro clinics personalized medicine research project (pmrp): Design methods and recruitment for a large population-based biobank. Personalized Medicine. 2005;2:49-79.
11. Peters DG, Kassam A, St Jean PL, Yonas H, Ferrell RE. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke. 1999;30:2612-2616.
12. Shimajiri S, Arima N, Tanimoto A, Murata Y, Hamada T, Wang KY, et al. Shortened microsatellite d (CA) 21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett. 1999;455:70-74. (Pubitemid 29322784)
13. St Jean PL, Zhang XC, Hart BK, Lamlum H, Webster MW, Steed DL, et al. Characterization of a dinucleotide repeat in the 92 kDa type IV colla-genase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease. Ann Hum Genet. 1995;59(Pt 1):17-24.
14. Yoon S, Tromp G, Vongpunsawad S, Ronkainen A, Juvonen T, Kuivaniemi H. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun. 1999;265:563-568.
15. Armani C, Curcio M, Barsotti MC, Santoni T, Di Stefano R, Dell'omodarme M, et al. Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm. Biomed Pharmacother. 2007;61:268-271. (Pubitemid 46891720)
16. Akaike H. A new look at the statistical model identification. IEEE Trans Aut Cont. 1974:716-723.
17. Mosteller F Association and estimation in contingency tables. J Am Stat Assoc. 1968:1-28.
18. Olson MW, Bernardo MM, Pietila M, Gervasi DC, Toth M, Kotra LP, et al. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromely-sin 1. J Biol Chem. 2000;275:2661-2668. (Pubitemid 30082034)
19. Zhang B, Henney A, Eriksson P, Hamsten A, Watkins H, Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet. 1999;105:418-423.
20. Petersen E, Wågberg F, Angquist KA. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Eur J Vasc Endovasc Surg. 2002;23:153-157. (Pubitemid 41079479)
21. Lindholt JS, Heickendorff L, Vammen S, Fasting H, Henneberg EW Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2001;21:235-240. (Pubitemid 32529981)
22. Baxter BT, Terrin MC, Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation. 2008;117:1883-1889. (Pubitemid 351507477)
23. Abdul-Hussien H, Hanemaaijer R, Verheijen JH, Van Bockel JH, Geelkerken RH, Lindeman JH. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content. J Vasc Surg. 2009;49:741-749.
24. Jones GT, Phillips VL, Harris EL, Rossaak JI, Van Rij AM. Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm. J Vasc Surg. 2003;38:1363-1367. (Pubitemid 37517670)
25. Ogata T, Shibamura H, Tromp G, Sinha M, Goddard KA, Sakalihasan N, et al. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg. 2005;41:1036-1042. (Pubitemid 40813036)
26. Maqbool A, Turner NA, Galloway S, Riches K, O'Regan DJ, Porter KE. The -1562C/T MMP-9 promoter polymorphism does not predict MMP-9 expression levels or invasive capacity in saphenous vein smooth muscle cells cultured from different patients. Atherosclerosis. 2009;207:458-465.
27. Wang Z, Lu S, Liu C, Zhao B, Pei K, Tian L, et al. Expressional and epi-genetic alterations of placental matrix metalloproteinase 9 in preeclamp-sia. Gynecol Endocrinol. 2010;26:96-102.
28. Roach HI, Yamada N, Cheung KS, Tilley S, Clarke NM, Oreffo RO, et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 2005;52:3110-3124. (Pubitemid 41447092)
29. Jones A E S R, O'Quinn EC, Black LE, Barth JL, Elefteriades JA, Bavaria JE, et al. Selective microrna suprresion in human thoracic aneurysms: Relationship of mir-29a to aortic size and proteoltic induction. Circulation Cardiovascular Genetics. 2012:605-613.
30. Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 2010;1803:55-71.